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Glossary 
AV-PEP           Antiviral post-exposure prophylaxis 
 
COPD    Chronic Obstructive Pulmonary Disease 
 
CYPSE   Children and Young People Secure Estate (CYPSE) 
 
DfE    Department for Education 
 
DHSC    Department of Health and Social care 
 
FES    Field Epidemiology Service 
 
HCWs             Healthcare Workers 
 
HMPPS YCS   HM Prisons and Probation Service Youth Custody Service 
 
HPT    Health Protection Team 
 
ILI    Influenza-like Illness 
 
IRC    Immigration Removal Centre 
 
JCVI    Joint Committee on Vaccination and Immunisation 
 
MoJ                 Ministry of Justice 
 
NICE    National Institute for Health and Care Excellence 
 
NIS    National Infection Service 
 
OCT    Outbreak Control Team 
  
PGD    Patient Group Direction 
 
PHE    Public Health England 
 
PPD    Place of Prescribed Detention 
 
PPE    Personal Protective Equipment 
 
PPO                Prison and Probation Ombudsman 
 
PSD    Patient Specific Direction 
 
SCH                                   Secure Children’s Home 
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STC                                   Secure Training Centre 
 
SOP    Standard Operating Procedure 
 
YCS Placement Team  Youth Custody Service Placement Team 
 
YOI                                      Young Offender Institution 
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1. Introduction 
This guidance is for healthcare and residential/care staff in the Children and Young 
People Secure Estate (CYPSE) in England. It has been developed by Public Health 
England’s (PHE) National Health & Justice Team in collaboration with the Respiratory 
Diseases Department, National Infections Service Centre for Disease Surveillance and 
Control, NHS England Health & Justice Commissioners, Her Majesty’s Prisons and 
Probation Service Youth Custody Service (HMPPS YCS) for their expertise and support 
in developing the guidance. This guidance considers children and young people (under 
18s) in the children and young people secure estate. Specific guidance for the adult 
detained and secure estate is published at:  
 
www.gov.uk/government/publications/seasonal-flu-in-prisons-and-detention-centres-in-
england-guidance-for-prison-staff-and-healthcare-professionals  
 
The children and young people secure estate 
The children and young people secure estate (under 18s) currently includes: 
 
• 4 under-18 Young Offender Institutions (YOIs)  
• 3 Secure Training Centres (STCs) 
• 15 Secure Children’s Homes 
 
Responsibility for commissioning health services in the secure estate sits with NHS 
England apart from Oakhill STC where healthcare is included within the private contract 
Commissioned by HMPPS YCS. 
 
Influenza (often referred to as flu) is an acute viral infection of the respiratory tract 
(nose, mouth, throat, bronchial tubes and lungs) characterised by a fever, chills, 
headache, muscle and joint pain, and fatigue1. For otherwise healthy individuals, flu is 
an unpleasant but usually self-limiting disease with recovery within 2 to 7 days. Flu is 
easily transmitted and even people with mild or no symptoms can still infect others. The 
risk of serious illness from influenza is higher among children under 6 months of age, 
older people and those with underlying health conditions such as respiratory disease, 
diabetes, cardiac disease or immunosuppression, as well as pregnant girls and women.  
 
Maintaining the operational effectiveness of the CYPSE is essential to preserve a fully 
functional youth justice and welfare estate, and this makes it desirable to minimise the 
impact of seasonal flu within these settings. 
                                            
 
1 PHE, Annual flu programme webpage (updated August 2019) www.gov.uk/government/collections/annual-flu-programme  
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1.1 Background 
The CYPSE runs the risk of significant and potentially serious outbreaks, with large 
numbers of cases and potentially a higher rate of complications including mortality 
because: 
 
• the enclosed nature of the CYPSE and the fact that children and young people are 
living in close proximity to each other means that flu can spread quickly   
• there may be considerable movement of children and young people within the estate 
• access to and capacity of healthcare could be limited if demand is high or care is 
complicated 
• children and young people in the secure estate may have a higher prevalence of 
respiratory illness (including asthma) immunosuppression and other chronic 
illnesses such as diabetes, than their peers in the community  
 
A key principle in managing cases or outbreaks of seasonal flu is that children and 
young people in the CYPSE should receive healthcare equivalent to their peers in the 
wider community including access to antiviral treatment, although the means of 
delivering such healthcare may differ from community models. 
 
An essential element of reducing the impact of influenza in the CYPSE is a whole-
setting approach to the prevention, early identification and notification of illness and 
prompt access to treatment including antivirals.  
 
The role of the National Health & Justice Team 
Flu is an unpredictable disease, and the impact on the CYPSE is hard to predict. PHE’s 
National Health & Justice Team provides expert advice and support to responding 
Health Protection Teams (HPTs) and outbreak control teams (OCTs), conduct 
surveillance at national level share intelligence with key partners and develop national 
guidance for use in preventing and managing outbreaks. Surveillance data on the 
number of outbreaks and their impact is collected centrally by the National Health & 
Justice Team, and this helps to inform real-time operational response as well as support 
planning and preparation.  
 
Last year’s flu season 
The 2018 to 2019 flu season saw fewer confirmed outbreaks of seasonal flu reported in 
prescribed places of detention (PPDs) across England and Wales than in 2017/18. In 
total, 13 confirmed outbreaks of flu A or B were reported to the National Health and 
Justice team compared with 21 in the preceding year. The majority of the reported 
outbreaks occurred in adult prisons in England, but 1 outbreak occurred in a prison in 
Wales and 2 separate outbreaks were reported in the same IRC in England (Figure 1).  
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In addition to fewer flu outbreaks reported than in the preceding year, fewer cases were 
also reported, on average, in each outbreak: 10.6 cases per outbreak in 2018/19 
compared with 24.3 cases per outbreak in 2017/18. However, despite these apparent 
reductions in outbreak frequency and size, a greater proportion of cases had serious 
complications secondary to their infection which required hospitalisation: 7.1% of 
prisoners/detainees were hospitalised in 2018/19 versus 2.6% in the preceding year. 
Sadly, one prisoner also died as a result of complications secondary to their flu 
infection. 
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Figure 1: Influenza outbreaks in the secure and detained estate (England and Wales; 2018 to 2019 flu season) by date 
reported, facility type, region and notification and closure dates. HMP = Her Majesty’s Prison; IRC = immigration removal 
centre. Source: National Health and Justice Team, PHE 
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2. Recommendations for action 
2.1 Preparation 
The public health principles guiding action within the CYPSE are the same as those in 
the wider community, that is: 
 
• vaccination of clinical risk groups (children and young people and all staff – (see 
Appendix 1)  
• vaccination of healthcare staff working in the CYPSE according to national 
guidance2 as detailed in Chapter 19 of the ‘Green Book’ 
• vaccination of residential/care staff who provide equivalent of a social care function 
to children and young people ill with flu in their rooms2.  
• prompt diagnosis (including assessing whether there is an outbreak) 
• ensuring effective and appropriate care including access to antivirals for individuals 
who are ill or to prevent infection in those at risk of complications 
• good infection control practice and resources to prevent transmission. PHE 
recommend that healthcare teams appoint a Flu Lead to oversee preparations 
including the seasonal flu vaccine campaign.  
 
The CYPSE should agree clear arrangements with their PHE HPT and NHS England & 
NHS Improvement Health & Justice Children’s Commissioners to ensure they know 
how to: 
 
• order vaccine supplies in good time and co-ordinate vaccination of eligible 
individuals  
• recognise possible outbreaks and report them quickly (see Multi-agency 
contingency plan for disease outbreaks in prisons)3  
• access public health advice and support, both in and out of office hours 
• rapidly access viral testing (and processing of swabs) to support the need for timely 
diagnosis and “low threshold to treat” policy for at clinical risk groups  
• provide antiviral medication 
• ensure adequate personal protective equipment is in stock 
 
 
                                            
 
2 PHE, Influenza: the green book, chapter 19 (updated 15 August 2018) 
www.gov.uk/government/uploads/system/uploads/attachment_data/file/456568/2904394_Green_Book_Chapter_19_v10_0.pdf  
3 Multi-agency contingency plan for disease outbreaks in prisons, January 2017 www.gov.uk/government/publications/multi-
agency-contingency-plan-for-disease-outbreaks-in-prisons 
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2.1.1 Vaccination for children and young people 
The aim of the immunisation programme is to protect those who are at risk of serious 
illness or death and to reduce transmission. Healthcare teams should compile a 
register of people for whom influenza immunisation is recommended. Sufficient vaccine 
can then be ordered in advance and individuals can be invited to planned immunisation 
sessions or appointments. The recommended flu vaccines for children and young 
people are detailed in the annual flu letter. Vaccinations should be offered, ideally 
before influenza viruses start to circulate (in late September/ early October), to those in 
defined clinical risk groups as outlined in the annual flu letter.   
 
All children aged 2 to 10 years old (but not 11 years or older) on 31 August 2019 
should be given the flu vaccination. It is worth noting that there are a large number of 
children within secure settings who may not have been in mainstream education and so 
may have missed the opportunity to receive routine childhood vaccinations for which 
they are eligible.  
 
Children and young people between 10 years and under 18 years of age who are in a 
clinical at risk group as set out in Appendix 1. NB This list is not exhaustive, and the 
healthcare practitioner should apply clinical judgement to take into account the risk of 
flu exacerbating any underlying disease that a patient may have, as well as the risk of 
serious illness from flu itself. Flu vaccine should be offered in such cases even if the 
individual is not in the clinical risk groups specified above. 
 
Working with pregnant young women 
 
There may be girls and young women within the CYPSE who are pregnant and they 
should be encouraged to have the flu vaccination. Consideration should also be given 
to their babies when born who fall into a risk group and are eligible for the vaccine.  
 
2.1.2 Flu vaccination for staff 
Different settings across the CYPSE will have various occupational health 
arrangements for residential/care and healthcare staff and it is important to include staff 
vaccination as part of flu preparation planning. It is strongly recommended that as part 
of the CYPSE flu strategy there is clear information on vaccine coverage for all 
appropriate staff groups.  
 
All Healthcare staff in direct contact with children and young people should be offered 
flu vaccination by their employer similar to healthcare staff in the community. This 
should form part of the organisation’s policy for the prevention of transmission of flu 
and should link directly to the organisation’s occupational health policy. New guidance 
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is available for healthcare providers so they can vaccinate their own staff using a peer 
to peer approach to maximise access to the vaccine to their employees4 
 
Non-healthcare staff working with children in the CYPSE who have close contact with 
children and young people affected by flu, for example, checking children in their 
rooms, undertaking searches, providing food, drinks and medication or providing other 
close personal care, should be offered the seasonal flu vaccine by the relevant 
occupational health provider for their organisation. This should form part of the 
organisation’s policies for the prevention of transmission of flu to help protect patients, 
and service users as well as staff and wider groups.  
 
Residential/care staff who are in clinical risk groups (Appendix 1) can access vaccine 
free of charge from their GP practice or pharmacies participating in the NHS seasonal 
flu influenza vaccination programme.   
 
Occupational Health providers should provide information to CYPSE senior leaders on 
the number of staff in clinical risk groups and their vaccine status (without providing 
patient identifiable information). 
 
2.2.3 Vaccination targets, coverage and recording  
 DHSC vaccination targets for the 2019/20 season are: 
 
• vaccination at least 65% of primary school aged children  
• vaccination of at least 55% of those in all clinical risk groups and maintain higher 
rates where those have already been achieved – ultimately, the aim is to achieve at 
least a 75% uptake in these groups given their increased risk of morbidity and 
mortality from flu 
• vaccination of at least 100 % of HCWs and other non-healthcare staff providing 
close personal care (see above) 
  
For children and young people both the offer and uptake of the flu vaccine should be 
recorded. Healthcare providers are encouraged to hold a register so that they can 
identify all children eligible for the flu vaccine. Updating the eligibility register throughout 
the flu season  will help with coordination of the local flu vaccination programme. Risk 
group status should also be recorded on SystmOne or equivalent clinical IT system 
paying particular attention to the inclusion of girls and young women who could become 
pregnant and individuals who enter at risk groups during the flu season. 
 
                                            
 
4 NHS Specialist Pharmacy Service: Written instruction for the administration of flu vaccine 2019: 
www.sps.nhs.uk/articles/written-instruction-for-the-administration-of-seasonal-flu-vaccination  
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For staff groups, HCWs should be included in their employers’ seasonal flu vaccination 
programme as per national guidance for healthcare staff, with target uptake of at least 
100% given the additional concern about flu outbreaks in closed secure settings. 
 
For non- healthcare staff with close contact with children and young people, individual 
employers should advise staff of the need to be vaccinated and how to access 
vaccination through occupational health or other services. Staff in clinical risk groups 
should receive vaccine through their GP/pharmacies participating in the NHS seasonal 
flu programme, free of charge, as per the rest of the population. There is a target 
uptake of vaccination of at least 100% of staff in roles analogous to health and social 
care workers.  
 
2.14 Accessing vaccine supplies 
Healthcare providers access influenza vaccines in the same way as GP practices as 
detailed in Chapter 19 Green Book2. 
 
Vaccine supplies  
 
Healthcare providers, or providers who provide childhood vaccination programmes to 
the CYPSE, should order flu vaccine supplies directly through the Immform website. 
Sufficient vaccine should be ordered based on past and planned performance and 
expected demographic increase to ensure that everyone at risk is offered flu vaccine. 
Ordering controls are in place to reduce the amount of excess vaccine ordered by NHS 
providers but not used. The latest information on ordering controls and other ordering 
advice for vaccines will be available on the PHE Vaccine Update and on the ImmForm 
website. 
 
In the event of an outbreak of seasonal flu vaccine stock can be sourced from the 
following in priority order: 
 
• Immform- providers will need to explain the basis of the increased need to as this 
will exceed estimates for the current season or the outbreak may happen outside 
the season 
• pharmacy service providers contracted to provide pharmaceutical services to the 
CYPSE 
• vaccine manufacturers 
 
Administration of influenza vaccines 
 
Influenza vaccines can be administered via a prescription or via a Patient Group 
Direction (PGD). A PGD is used for vaccinating a number of people for example, as 
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part of nurse or pharmacist-led vaccination clinics. A Patient Group Direction (PGD) 
must be used in line with legislation and NICE Guidance5.  
  
Ideally PGDs need to be in place all the time and reviewed in advance of the flu season 
so they are ready for use for flu vaccination clinics and when the Chief Medical Officer 
advises the NHS that antivirals can be used for flu (see 2.5) 
 
NHS England commissioners within individual NHS England regions or localities 
usually authorise a flu vaccine PGD that can be shared and used by GP practices and 
health and justice providers within that locality/region. Where providers cannot access 
a local NHS England authorised PGD, the PHE template PGD for the vaccine 
(available here6) can be used by providers to either authorise within their organisation 
(for NHS Trusts) or to gain NHS England authorisation for its use (for non- NHS 
healthcare providers)  
 
NB: Please note that Oakhill STC, which has healthcare commissioned by HMPPS 
YCS must have the PGD authorised by the establishment director and not NHS 
England. 
 
2.2 Diagnosis and recognition of a case 
It is important that all staff (residential/care staff as well as healthcare) are aware of the 
symptoms of influenza-like illness (ILI) and of the need to report possible cases 
promptly during the winter flu season to healthcare. Residential/care staff often have 
the most contact with children and young people and are therefore well-placed to 
recognise increasing number of cases. Employees with signs and symptoms of ILI 
should seek advice from their GP and inform their line manager and occupational 
health provider. 
 
During the flu season, the majority of single cases will be diagnosed by healthcare staff 
on clinical grounds only based on the following clinical signs & symptoms and 
recognition of a case7.  
 
Prompt action is necessary if ILI is suspected. A useful case definition for flu cases is 
provided in Table 1 below - this case definition may be modified once an OCT is called: 
 
 
 
                                            
 
5 NICE. Good practice guidance Patient Group Directions August 2013 www.nice.org.uk/guidance/mpg2 
6 PHE template for PGD (flu vaccine) www.gov.uk/government/publications/intramuscular-inactivated-influenza-vaccine-
patient-group-direction-pgd-template  
7  European Centre for Disease Prevention and Control, EU case definitions http://eur-lex.europa.eu/legal-
content/EN/TXT/PDF/?uri=CELEX:32012D0506&qid=1428573336660&from=EN#page=16  
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Table 1: Influenza (Influenza virus), clinical criteria for case definitions. Source: 
World Health Organisation8 
 
ILI case definition 
 
An acute respiratory infection with: 
• measured fever of ≥ 38 C° 
• and cough; 
• with onset within the last 10 days 
 
 
Swabbing to confirm infection 
CYPSE healthcare teams should swab the first few presenting cases (up to 5) as soon 
as possible.  
 
Once flu is confirmed, all other cases meeting the clinical case definition are regarded 
as suspected flu and no further testing is advised.9 However, the OCT may consider 
further testing towards the end of the outbreak to confirm that any new cases 
presenting with ILI can be discounted or in more complex situations, eg multiple 
wings/units with ILI or in more complex situations  
 
Isolation and cohorting of cases: 
Children presenting with ILI should be isolated in single room accommodation and 
clinically assessed as soon as possible by the healthcare team. They should remain 
isolated until assessment. If a suspected case, they should continue to be isolated until 
resolution of their symptoms (usually 5 days from onset but may be longer in people 
with underlying medical conditions). 
 
Cohorting of cases: Ideally, children with suspected/confirmed cases of flu should be 
isolated in single accommodation. Where demand exceeds capacity, cases may be 
cohorted together (doubling up). Where cases are concentrated in a particular unit or 
part of the secure setting, the OCT may consider cohorting all other cases in the same 
place but this may not be practicable. 
 
Asymptomatic room sharer contacts of cases: where there are 2 or more people in a 
room and one becomes a suspected case, those room sharers’ contacts may be 
incubating infection or have sub-clinical or mild infection. However, because they pose 
                                            
 
8 www.who.int/influenza/surveillance_monitoring/ili_sari_surveillance_case_definition/en/ 
9 You may consider swabbing children in clinical risk groups 
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an infection control risk, they should also be isolated from the general population 
(generally for 48 hours since last exposure). Practical operational considerations will 
need to inform any decision whether that means they stay where they are or can be 
moved to another location away from the ill roommate. 
 
2.3 Treatment and care  
 
Symptomatic care should be offered including bed rest and oral fluids with paracetamol 
and/or ibuprofen provided as clinically indicated. 
 
The use of antivirals for prophylaxis and treatment of influenza according to NICE 
guidance10,11 remains an integral part of influenza control measures for closed secure 
settings. Public Health England has published additional guidance on the use of 
antivirals12 which should be consulted. 
 
Children and young people with suspected flu that are in clinical risk groups for 
complications of infection (see Appendix 1) should be considered for treatment with 
antivirals (usually oseltamivir more commonly known as Tamiflu). PHE recommends 
the consideration of treatment even in vaccinated children and young people.  
 
Antiviral post-exposure prophylaxis of close contacts 
 
Use of antivirals for post-exposure prophylaxis (AV-PEP) is advised for those contacts 
of cases that are in clinical risk groups, regardless of seasonal flu vaccine status 
(although this lies outside of NICE guidance). Where there is an extensive outbreak, 
the OCT should consider offer of AV-PEP to all those in clinical risk groups in affected 
parts of or throughout the secure setting. 
 
2.3.1 Accessing supplies of antivirals 
The CYPSE flu plans should include details of the ordering process and supply of 
antivirals. These plans need to take into account the need for patients to commence 
antivirals within 36-48 hours of symptom onset, as appropriate. All supplies of antivirals 
to children should be recorded in their clinical records. Tamiflu can be supplied in-
                                            
 
10 Guidance on the use of antiviral drugs for the prevention of influenza (Technology Appraisal Guidance No.158) 
www.nice.org.uk/guidance/ta158  
11 NICE. Guidance on the use of antiviral drugs for treatment of influenza (Technology Appraisal Guidance No. 168) 
www.nice.org.uk/guidance/ta168  
12 Guidance on antiviral agents for the treatment and prophylaxis of Influenza (January 2019) 
www.gov.uk/government/publications/influenza-treatment-and-prophylaxis-using-anti-viral-agents  
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possession unless the child or young person is unable to manage their medicines. 
Alternative antivirals13,14 are available for patients who are unable to take Tamiflu. 
 
There are 2 routes for children to access antivirals following a clinical assessment and 
diagnosis: 
 
Individual prescriptions or patient specific direction (PSD): The antiviral can be 
accessed by sending the prescription to the pharmacy for dispensing (ie the pharmacy 
contracted to provide medicines to the CYPSE or an out of hours pharmacy) OR by 
using over-labelled stock supplies15 that allow the prescriber or registered healthcare 
professional to add the patient name and date to enable a prompt supply to the patient. 
This should be completed using standard operating procedures (SOPs) developed and 
ratified by the healthcare provider. 
 
A Patient Group Direction (PGD) authorised and handled as per NICE Guidance:  
 
PHE has produced 2 PGD templates16 for flu AV-PEP and treatment. These were 
designed for use in care homes only can be adapted for secure settings. These PGDs 
cover: 
 
• Tamiflu for the treatment of flu-like symptoms 
• Tamiflu for the prophylaxis of people at risk of getting the flu and who meet specific 
criteria 
 
In-possession supplies, made under a PGD must be handed to the child or young 
person by the healthcare professional who assesses the child or young person. For 
non-IP supplies, the healthcare professional who assesses the child or young person 
can supply the antiviral for storage so that doses can be administered under 
supervision in line with local arrangements. The antiviral supplied via a PGD must be 
from over-labelled stock and the name of the patient and the date added to the label by 
the healthcare professional 
 
NB: During an outbreak PHE may recommend that staff in clinical risk groups should be 
considered for post exposure prophylaxis with antiviral medication (Appendix 4). This 
would usually be provided by a GP. Some outbreaks may need a longer duration option 
                                            
 
13 NICE Clinical Knowledge Summaries. Influenza – seasonal: prescribing information https://cks.nice.org.uk/influenza-
seasonal#!prescribinginfo  
14https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/773369/PHE_guidance_a
ntivirals_influenza.pdf) 
15 Over-labelled supplies must be procured from a licenced provider. The label usually has the dose pre-printed on it and 
allows the healthcare professional to add the patient name and date at the point of supply 
16 Influenza post exposure prophylaxis and treatment: PGD templates www.gov.uk/government/publications/influenza-post-
exposure-prophylaxis-and-treatment-pgd-templates  
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of prophylaxis for high risk people. Up to 42 days of prophylaxis can be given within the 
product licence of Tamiflu. 
 
If a PGD is not in place when an outbreak becomes likely or begins commissioners and 
providers can:  
 
•  write prescriptions for antivirals or flu vaccinations until a PGD is in place 
• NHS trust healthcare providers can authorise their own PGDs and so can use their 
own mechanism to fast track the development and authorisation of PGDs for flu 
vaccine and Tamiflu  
 
Non-NHS providers cannot authorise their own PGDs but should have a mechanism to 
write the PGD and submit it for authorisation by the NHS England local commissioner. 
(H&J commissioners need to identify who the PGD authoriser is for their local team and 
facilitate the rapid PGD authorisation through this local process)  
 
2.3.2 Stock access of flu vaccine and antivirals 
Flu vaccine is supplied from Immform for people under 18 years old. 
 
Antivirals supplied under a PGD are usually sourced already over-labelled from the 
provider’s usual supplier of pre-packs/over-labelled medicines. For urgent supply 
during an outbreak it is acceptable for the antiviral to be supplied by adding the patient 
name, date and site name to the manufacturer’s pack and giving verbal instructions to 
the person about the dose, advising them to read the patient leaflet in the pack and to 
contact healthcare staff if they have any queries whilst taking it. See also PGD Q&A.17  
 
Antiviral stock access should be checked and confirmed by commissioners in an 
outbreak and support to access urgent stock may be needed (eg supported by PHE 
colleagues). Potential stock from regional stockpiles is a last resort AND will only be 
activated if this can be accommodated by the pharmacy holding this supply and only if 
all costs for replacement of antivirals and pharmacy charges are directly reimbursed by 
the commissioner to the pharmacy.  
 
Where stock supplies of over-labelled antivirals are used, plans should include: 
 
• agreement of minimum stock levels based on previous year’s use with plans to 
amend this during an outbreak. 
                                            
 
17 www.sps.nhs.uk/articles/what-are-the-legal-requirements-for-labelling-a-prescription-only-medicine-pom-issued-via-a-pgd-
before-supply-to-the-patient/  
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• processes to check the antiviral stock regularly to ensure appropriate storage and 
expiry dates, audit the supplies made and re-order stock should this fall below 
minimum levels 
 
2.4 Prevention of transmission of infection 
Detailed information on Infection control precautions to minimise transmission of acute 
respiratory tract infections in healthcare settings18 
 have been published by PHE and can also guide action in the CYPSE, advising that: 
 
• during the winter flu season, children and young people with ILI should be 
diagnosed early and isolated to prevent further spread 
• children and young people with ILI should be promptly assessed and isolated on 
their own or cohorted with other cases as soon as possible 
• where demand for isolation exceeds capacity, consideration should be given to 
cohorting, with appropriate risk assessment of suitable cohortees, and the need for 
the movement of children and young people in, out and around the secure setting 
should be reconsidered with a view to reducing these movements 
 
Visiting  
Symptomatic visitors should be excluded until no longer symptomatic and visitors with 
underlying health conditions and at risk of more severe infection (see Appendix 1) 
should be discouraged from visiting during an outbreak. Consistent with patient welfare, 
visitor access to symptomatic children and young people should be kept to a minimum. 
Any visitors should be provided with hygiene advice. Non-urgent visits should be 
rescheduled until after the outbreak is over. 
 
2.5 Outbreaks within the CYPSE 
If a seasonal flu outbreak is suspected or confirmed, it is strongly recommended that 
PHE Health Protection Teams convene an outbreak control team (OCT) meeting (for 
detailed guidance on the role of OCTs in prison or other detention settings see the 
Multi-agency contingency plan for disease outbreaks in prisons and other PPDs)3. The 
OCT will: 
 
• review information with partners on the extent and severity of infection (including 
information on patients requiring transfer out to hospital) 
                                            
 
18 Public Health England. Infection control precautions to minimise transmission of acute respiratory tract infections in 
healthcare settings- October 2016 www.gov.uk/government/publications/respiratory-tract-infections-infection-
control#history    
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• collect data on clinical attack rates to guide management of effective control 
measures 
• review and advise on infection control practice 
• consider vaccine coverage among children and staff groups and  
• consider role of antiviral treatment or prophylaxis for cases or contacts  
including staff  
 
The National Health & Justice Team should be invited to provide expert support, and 
experts from Field Services (FS) and/or the National Infection Service (NIS) should also 
be considered as contributors to the OCT. 
 
During an OCT, the following issues need to be considered: 
 
• if not already done, ensuring that testing for seasonal influenza is carried out (See 
section on swabbing above); 
• consideration of the need to offer vaccination 
• whether antiviral prophylaxis is required, who should receive it and how to include 
confirmation that a current in-date PGD is in place.  
• operational status of the secure setting re: transfers in and out/regime restrictions 
etc. 
• isolation and/or cohorting children and young people as part of wider infection 
control practice 
• ensuring that, where possible, staff either deal with children who are symptomatic or 
asymptomatic but not both 
• managing hospital admission if required 
• communication and media issues 
 
Specific infection control considerations: 
 
• hand and respiratory hygiene measures should be re-emphasised to help minimise 
the spread of the infection (for both children and young people and staff) 
• chlorine based/bleach products are recommended by PHE for use in disinfecting 
and deep cleaning contaminated areas for infection control purposes; new guidance 
was published by PHE and HMPPS in 2017 on the use of Titan-Chlor tablets for 
cleaning purposes on recommendation of the OCT (see Appendix 3)  
• if a symptomatic case needs to pass through areas where other people are waiting 
then they should wear a fluid repellent surgical mask 
• residential healthcare staff who are assessing children with suspected ILI and 
coming into close contact (less than 1 metre) to provide care should wear 
appropriate personal protective equipment (PPE), as per national guidance18 
 
During any outbreak, residential/care and healthcare staff with ILI should be excluded 
from work and be managed by their GP if they are in specific clinical risk groups: 
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• if staff become ill at work, they should be sent home immediately or isolated until 
they can be sent home 
• custodial staff with flu-like illnesses at home should seek medical care in the 
community using the usual mechanisms (ie via their GP if they belong to specific 
clinical risk groups) 
• During an outbreak of influenza cases among staff should be reported to the HPT 
as well as cases among children and young people 
 
Specific considerations about communications during an outbreak: 
 
• PHE may recommend that staff in clinical risk groups should be considered for post 
exposure prophylaxis with antiviral medication. (Appendix 4).  
• a letter (see Appendix 5) can be issued to staff to inform them of the outbreak and 
provide relevant advice 
 
Specific considerations for the CYPSE around population management during an 
outbreak  
Where an outbreak has been declared, a dynamic risk assessment form should be 
completed by the governor/director/manager and the PHE Consultant in Health 
Protection leading the OCT (see Appendix 6). Appendix 2 includes information on the 
process for limiting movements of affected children and young people and should be 
discussed as part of the OCT.  
 
The OCT may consider recommending:  
 
Restricting transfers out to other secure settings − this is to avoid ‘seeding’ an 
outbreak in other establishments; where required for security reasons, the receiving 
secure setting should be notified of outbreak. Avoid transferring symptomatic children 
as a priority − all infection control advice should be followed if transfers required. 
 
Restricting new receptions − this is to avoid ‘feeding’ an outbreak by introducing new 
vulnerable cases to the establishment; if it is not possible to restrict completely, new 
receptions should be:  
 
• assessed to determine if in a risk group and if in a risk group considered for AV PEP 
and vaccine  
• assessed for signs & symptoms of flu and symptomatic children who have just 
arrived at the secure setting should be isolated/cohorted immediately 
• symptomatic children in clinical risk groups coming in from community may be 
swabbed and considered for treatment dose of antivirals if clinically appropriate 
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Transfers to court 
In an outbreak situation, symptomatic children and young people may not be suitable 
for court due to consideration both of clinical needs and infection control. Courts should 
be advised that a child/young person is ill with flu and therefore may not be suitable for 
court appearance: 
  
Where it is necessary to have a symptomatic child/young person attend court, a video 
link to the court should be considered as an alternative to personal appearance.  
 
If personal appearance is required, appropriate infection control measures should be 
implemented as per appropriate guidance.  
 
New allocations from court 
Consideration should be given to redirecting new children and young people allocated 
to an infected site. It should be noted, however, that in some circumstances, this may 
be sustainable for no more than a few days at most.  
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Appendix 1 
Influenza vaccination should be offered to people in the clinical risk categories below: 
 
Clinical risk 
category 
Examples (this list is not exhaustive and decisions should be 
based on clinical judgement) 
Chronic respiratory 
disease 
Asthma that requires continuous or repeated use of inhaled or 
systemic steroids or with previous exacerbations requiring 
hospital admission. 
Chronic obstructive pulmonary disease (COPD) including 
chronic bronchitis and emphysema; bronchiectasis, cystic 
fibrosis, interstitial lung fibrosis, pneumoconiosis and 
bronchopulmonary dysplasia (BPD). 
Children who have previously been admitted to hospital for lower 
respiratory tract disease. 
see precautions section on live attenuated influenza vaccine 
Chronic heart 
disease 
Congenital heart disease, hypertension with cardiac 
complications, chronic heart failure, individuals requiring regular 
medication and/or follow-up for ischaemic heart disease. 
Chronic kidney 
disease 
Chronic kidney disease at stage 3, 4 or 5, chronic kidney failure, 
nephrotic syndrome, kidney transplantation. 
Chronic liver 
disease 
Cirrhosis, biliary atresia, chronic hepatitis 
Chronic 
neurological 
disease (included in 
the DES directions 
for Wales) 
Stroke, transient ischaemic attack (TIA). Conditions in which 
respiratory function may be compromised due to neurological 
disease (eg polio syndrome sufferers). Clinicians should offer 
immunisation, based on individual assessment, to clinically 
vulnerable individuals including those with cerebral palsy, 
learning disabilities, multiple sclerosis and related or similar 
conditions; or hereditary and degenerative disease of the 
nervous system or muscles; or severe neurological disability. 
Diabetes Type 1 diabetes, type 2 diabetes requiring insulin or oral 
hypoglycaemic drugs, diet controlled diabetes. 
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Immunosuppression  
(see 
contraindications 
and precautions 
section on live 
attenuated influenza 
vaccine) 
Immunosuppression due to disease or treatment, including 
patients undergoing chemotherapy leading to 
immunosuppression, bone marrow transplant, HIV infection at all 
stages, multiple myeloma or genetic disorders affecting the 
immune system (eg IRAK-4, NEMO, complement disorder) 
Individuals treated with or likely to be treated with systemic 
steroids for more than a month at a dose equivalent to 
prednisolone at 20mg or more per day (any age), or for children 
under 20kg, a dose of 1mg or more per kg per day. 
It is difficult to define at what level of immunosuppression a 
patient could be considered to be at a greater risk of the serious 
consequences of influenza and should be offered influenza 
vaccination. This decision is best made on an individual basis 
and left to the patient’s clinician. 
Some immunocompromised patients may have a suboptimal 
immunological response to the vaccine. 
Asplenia or 
dysfunction of the 
spleen 
This also includes conditions such as homozygous sickle cell 
disease and coeliac syndrome that may lead to splenic 
dysfunction. 
Pregnant women Pregnant women at any stage of pregnancy (first, second or 
third trimesters). 
see precautions section on live attenuated influenza vaccine 
Morbid obesity 
(class III obesity)* 
Adults with a Body Mass Index ≥40 kg/m² 
 
* Many of this patient group will already be eligible due to complications of obesity that place them in another risk category
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Appendix 2 
Command, control, co-ordination and communication in outbreaks of infections in 
the Children and Young People Secure Estate 
Where limiting movement to arrivals/transfers within the CYPSE this decision will be 
taken by the outbreak control team (OCT) with HMPPS YCS or Welfare Coordinating 
Unit and the following must take place: 
 
• the (OCT) should consider whether limiting movement should be to arrival, or 
transfers out of CYPSE only, ie is there an unaffected part of the secure setting that 
can be used so the secure setting can continue to accept new children, thus 
maintaining service to the Youth or Family Courts and also PACE and DCS directive  
• the OCT should consider whether full or partial limitation on movement is 
necessary, via the governor/director/manager, obtain from the YCS Placement 
Team or Welfare Co-ordination Unit an impact assessment of change in ability to 
receive new children or make transfers*  
• the assessment will outline the resulting pressure from such action and state the 
approximate time period for which change in activity of the secure setting can be 
sustained 
• the impact assessment must be considered by the OCT before deciding on whether 
to recommend to the YCS Head of Placements or Manager Welfare Coordinating 
Unit/LA to change activity, limit movement or close 
• only the YCS Director or Deputy Director should take decisions on closing a YOI, 
Secure Training Centre or Secure Children’s Home to new receptions and transfers, 
given their oversight of a greater proportion of the estate, the population of which 
will be impacted by any decision to close 
• if however the OCT and/or the YCS Director or Deputy Director or SCH registered 
manager wishes to limit movement, change activity or close the secure setting for a 
period beyond that which the YCS Placement Team or SWCU / placing LA deems 
sustainable (and in certain circumstances such action may be not be deemed 
sustainable for any time at all) then the recommendation must be escalated to the 
Director of YCS or the SCH provider for a final decision 
• if an urgent out of hours decision is required it should be made by the appropriate 
senior Director on duty 
• if a decision to limit movement, change activity or close has been taken then at least 
every 3 days a further impact assessment of continuing closure must be obtained 
from the YCS Placement Team or SCH registered manager. 
• the assessment should be provided to the YCS Director along with up-to-date 
information as to the current status of the outbreak 
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“The impact assessment will consider the impact on the surrounding CYPSE of any 
restrictions on reception or discharge and the duration for which restrictions are 
considered sustainable” 
 
• the YCS Director or registered manager should then maintain or withdraw his/her 
decision to limit movement, change activity or close the establishment to receptions 
and transfers 
• again, should the YCS Placement Team or SCH registered manager’s assessment 
determine that continuing change of activity or closure is unsustainable, any 
decision to extend the change of activity must be made by the YCS Director (or duty 
director in urgent out-of-hours circumstances) 
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Appendix 3 
Guidance for the use of Titan Chlor Tablets® for Surface and Artefact 
Disinfection and Cleaning 
As part of infection control measures including the management of gastrointestinal 
infection outbreaks in prisons and other places of detention 
Titan Chlor tablets are chlorine-based/bleach disinfectant tablets and are available for 
order by Prisons and OPDs from the Greenham catalogue. Chlorine-based/bleach 
products are recommended by Public Health England for use in disinfecting and deep-
cleaning contaminated areas during, or following, an outbreak of gastrointestinal 
infection as well as for cleaning for other infection control purposes. Chlorine 
inactivates most pathogens such as bacteria and viruses. 
 
During an outbreak situation, use of chlorine-based disinfectants may be advised as 
part of the control measures and/or to deep clean an area potentially contaminated, 
especially in outbreaks of gastrointestinal illness accompanied by diarrhoea and 
vomiting, but also for other outbreaks including influenza. Use of chlorine-based 
disinfectant products (eg. Titan Chlor tablets) and other cleaning products will be 
advised by the Outbreak Control Team (OCT). Advice on how to use chlorine-based 
disinfectants and other cleaning products is available in guidance published by PHE in 
“Prevention of Infection and Communicable Disease Control in Prisons and Places of 
Detention” 19 The role of the OCT, its membership and responsibilities are described in 
guidance published by HM Government/Public Health England/NHS England in the 
guidance document ‘Multi-agency Contingency Plan for the Management of Outbreaks 
of Communicable Diseases or Other Health Protection Incidents in Prisons and Other 
Places of Detention in England’ 20178. 
 
This guidance must be read in conjunction with local COSHH risk assessments and 
safe systems of work relating to Titan Chlor tablets/bleach based cleaning products  
 
For compliance with COSHH Regulations including storage, handling, use, signage, 
training, information, emergency procedures and disposal, the Titan Chlor Safety Data 
Sheet (Ref Sealed Air – Diversey Care 6087338) is attached below and must be 
referred to, in association with the OCT, for the identification and development of any 
necessary local controls additional to those specified below  
                                            
 
19 Prevention of infection and communicable disease control in prisons and places of detention 
www.gov.uk/government/uploads/system/uploads/attachment_data/file/329792/Prevention_of_infection_communicable_diseas
e_control_in_prisons_and_places_of_detention.pdf  
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Guidance for general cleaning and action required to limit the further spread of 
infection 
Micro-organisms causing illness can be spread: 
 
• from person to person 
• from infected food 
• from contaminated water supplies 
• from other contaminated drinks (milk, fruit juices etc.) 
• from a contaminated environment 
• through all these means 
 
On detection of an outbreak, cypse sites should urgently seek advice from their local 
public health england centre health protection team (HPT). 
 
Actions to take in response to an outbreak: 
 
• children who are ill should be isolated in their rooms, usually until free of symptoms 
for 48 hours 
• room-mates of children who are ill may be incubating the illness themselves and 
should be similarly isolated 
• if there are no in-room sanitation facilities, make sure to reserve some toilet facilities 
for the use of symptomatic children only (eg all those with symptoms and up to 48 
hours after symptoms have disappeared)  
• place appropriate and clear signage on the toilet areas, such as ‘for D&V patients 
only’ and make sure the signs are clear for children with learning difficulties to 
understand 
• where toilet seats are present, make sure they are down before flushing 
• make sure cleaner(s) cleaning affected areas do not visit other parts of the secure 
setting 
• clean regularly and frequently throughout the day all hand-held surfaces in affected 
areas with a Titan bleach-containing agent or other appropriate product as advised 
by the OCT,  
• toilet seats, flush handles, wash-hand basin taps, surfaces and toilet door handles 
should be cleaned at least daily or more often, depending on use. 
• disposable gloves and cloths will be used for cleaning. These may be disposed of 
by placing them in yellow bio hazard bags and safely disposed of via an approved 
contractor 
• If reusable rubber gloves and non-disposable cloths are used by cleaners, these 
should be thoroughly washed in hot water and Titan Chlor bleach solution after use, 
rinsed and allowed to dry 
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• ideally mops with disposable heads should be used and mop heads should be 
either cleaned as above, or safely disposed of at the end of cleaning via yellow bio 
hazard bags 
• all mop heads used should be disposed of at the end of the episode of illness, via 
yellow bio hazard bags and an approved contractor. 
• no cleaning of soiled items should take place in food preparation areas 
• contaminated bedding should be handled with care and attention paid to the 
potential spread of infection. Personal protective equipment (PPE) such as plastic 
aprons and suitable gloves should be worn for handling dirty or contaminated 
clothing and linen. The washing process should have a disinfection cycle in which 
the temperature of the load is either maintained at 65ºC for not less than 10 minutes 
or 71ºC for not less than 3 minutes when thermal disinfection is used 
• hand washing is crucial for effective control: ensure that hand-cleaning facilities 
(liquid soap and warm water, paper towels, pedal-bins for the paper towels) are 
available and encourage people (both children and staff) to wash hands often and 
every time they use the toilet and before eating 
• personal protective equipment (PPE). Follow advice of the OCT on use of 
appropriate PPE such as single-use gloves and aprons when using bleach 
products. These products should be available within the prison/place of detention. If 
not, contact your PPE suppliers and place an urgent order for next day delivery 
• the OCT will declare when the outbreak is over 
• before resumption of normal regime, deep cleaning (terminal cleaning) may be 
needed (especially in norovirus outbreaks). The OCT will provide detailed advice. 
Where available, consideration should be given to the use of prisoners specifically 
trained in cleaning procedures for this task 
 
Guidance on the Use of Titan Chlor tablets/diluted solution 
Although primarily written to advise supervising residential/care staff, the guidance 
below is equally applicable to any trained person employed in using Titan Chlor 
products: 
 
• supplies of Titan Chlor tablets are to be securely stored at all times and may ONLY 
be used on the direction of an Outbreak Control Team (OCT) Senior Manager in 
response to an infection outbreak 
• very large bulk volumes should not be stored without a review of fire risk and control 
• Never issue Titan Chlor tablets to children for unsupervised use 
• before using Titan Chlor tablets ensure that all requirements arising from the 
supplier’s instructions, this guidance and additional local assessment are in place 
and understood by those concerned.   
• supervising officers must ensure that appropriate personal protective equipment 
(PPE) (gloves – vinyl/waterproof as a minimum) is utilised for all staff and children 
using Titan tablets 
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• never handle Titan tablets with wet unprotected hands 
• ensure Titan dilution levels are as specified by the manufacturer and that any child 
or young person 
• cleaners employed in its use are correctly risk assessed and are directly supervised 
at all times  
• Titan Chlor tablets, must never be used with or mixed with anything other than water 
to make a cleaning solution, they fizz when added to water to speed up the reaction 
but this is not the release of chlorine gas. However, mixing with any other liquid or 
adding any other solid substance to the solution may well release dangerous 
chlorine gas 
• if mixed with water (or worse, anything acidic) and then confined in a container a 
build-up of pressure can be achieved, with a risk of the container 
rupturing/exploding. Titan Chlor tablets should only be mixed with water and in an 
open container/bucket  
• if chlorine gas is released by mixing, the source solution should be discarded and 
flushed copiously down a sink, sluice or WC. Vents / windows to the outside should 
be opened if viable, internal doors closed and those in the room should seek 
medical advice 
• Titan bleach solution is harmful if swallowed and is irritating to the eyes and 
respiratory system if contact is made. Immediate medical attention should be sought 
if accidental contact occurs 
• supervising staff need to be vigilant at all times in the deployment of Titan Chlor 
solution and be aware of the potential for its use in attacking others/aiding self-harm  
• Any instance of misuse of Titan Chlor should be managed appropriately and 
reported via IRS and H&S channels 
• once cleaning is complete, ensure that COSHH directions for the controlled, safe 
and secure disposal of used diluted Titan bleach solution are followed 
• once cleaning is complete, ensure that all contaminated cleaning equipment and 
materials (eg mop heads/cleaning cloths/ disposable PPE) is cleaned as per the 
guidance above, or is placed in yellow bio hazard bags and safely disposed of via 
an approved contractor 
• ensure that any unused Titan tablets are securely stored/ideally returned to store 
and are kept in a clean and dry environment to prevent cross contamination with 
other chemicals 
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Appendix 4 
Information for CYPSE staff on use of antiviral medication in treatment and 
prevention of seasonal flu 
Dear colleague, 
 
You are being provided with this information leaflet because PHE have identified that 
there is an outbreak of seasonal flu in the place where you work and are working with 
HMPPS YCS, Department for Education and NHS England and NHS Improvement, to 
protect vulnerable children and staff who may be in clinical risk groups for 
complications of infection. 
 
Staff in clinical risk groups are normally offered vaccination through their GP or 
Occupational Health Services but even if you have been vaccinated recently, it is still 
possible to get flu.  
 
Therefore, PHE are recommending that residential/care staff that are in a risk group 
who work in children-facing roles should be considered for post-exposure prophylaxis 
with antiviral medication (AV PEP). The most commonly prescribed antiviral for this 
purpose is called Oseltamivir (Tamiflu). A list of clinical risk groups is provided at the 
end of this leaflet. 
 
Oseltamivir (Tamiflu) is used for influenza (flu) virus A and B infections. It treats flu by 
preventing the viruses from spreading once they are inside your body. This reduces the 
symptoms of the influenza infection or prevents you catching the flu from other people.  
 
Important: You are being offered Tamiflu to prevent infection. If you develop symptoms 
of flu you will need to be assessed by your GP and may require a ‘treatment dose’ to 
be prescribed following clinical assessment. You should advise your GP in this case 
that you work in a secure setting with a confirmed outbreak of flu and have been on 
prophylaxis with Tamiflu. 
 
Before taking oseltamivir 
 
Some medicines are not suitable for people with certain conditions, and sometimes a 
medicine can only be used if extra care is taken. For these reasons, before you start 
taking oseltamivir it is important that the healthcare professional knows: 
 
• if you are pregnant, trying for a baby or breast-feeding; although you can take 
oseltamivir if you are expecting or feeding a baby, it is important that your 
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healthcare professional should know about this so that you can be made aware of 
the benefits and any risks of treatment 
• if you have any problems with the way your kidneys work − this is because your 
dose may need adjusting 
• if you are taking or using any other medicines − this includes any medicines you are 
taking which are available to buy without a prescription, such as herbal and 
complementary medicines 
• if you have ever had an allergic reaction to a medicine 
 
How to take oseltamivir 
 
Before you start the treatment, read the manufacturer's printed information leaflet from 
inside the pack. It will give you more information about oseltamivir and it will provide 
you with a full list of side-effects which you may experience from taking it. 
 
Oseltamivir should be taken exactly as your healthcare professional tells  
you to.  
 
Oseltamivir is a course of treatment. It is important that you finish the whole course 
(even if you do not feel unwell). 
 
If you are taking it because you have been in contact with someone with flu but do not 
have any symptoms yourself then you will be prescribed 1 dose a day for at least 10 
days. Start taking the capsules (or medicine) as soon as you collect it, and from then 
on, take 1 dose a day, preferably in the morning with breakfast. 
 
Swallow oseltamivir capsules with a drink of water. You can take your doses either 
before or after meals, although taking the doses after food can often reduce the risk of 
feelings of queasiness. 
 
If you forget to take a dose, take it as soon as you remember (unless it is nearly time 
for your next dose, in which case leave out the missed dose). Do not take 2 doses 
together to make up for a forgotten dose. 
 
How to store oseltamivir 
 
Keep all medicines out of the reach and sight of children. 
 
Store in a cool, dry place, away from direct heat and light. 
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List of high-risk groups 
The Department of Health and Social Care, Public Health England and NHS England: 
Flu plan (winter 2018 to 2019) lists people with the following conditions as clinical risk 
groups for complications of infection with flu: 
  
• people aged 65 years or over (including those becoming age 65 years by 31 March 
2019)  
• people aged from 6 months to less than 65 years of age with a serious medical 
condition such as:  
o chronic (long-term) respiratory disease, such as severe asthma, chronic 
obstructive pulmonary disease (COPD) or bronchitis  
o chronic heart disease, such as heart failure  
o chronic kidney disease at stage 3, 4 or 5  
o chronic liver disease  
o chronic neurological disease, such as Parkinson’s disease or motor neurone 
disease, or learning disability  
o diabetes  
o splenic dysfunction  
o a weakened immune system due to disease (such as HIV/AIDS) or 
treatment (such as cancer treatment) morbidly obese (defined as BMI of 40 
and above)  
• all pregnant women (including those women who become pregnant during the flu 
season)  
• all children aged 2 to 9 (but not 10 years or older) on 31 August 2018  
• all primary school aged children in former primary school pilot areas 
• those in long-stay residential care homes or other long stay care facilities  
• carers  
• frontline health and social care workers 
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Appendix 5 
 XXXX Health Protection Team 
Public Health England 
INSERT ADDRESS 
 
T  +44 XXXXXXXXXXXX 
F  +44  XXXXXXXXXXXX 
 
www.gov.uk/phe 
 
Dd/MM/2019 
 
To members of staff at [YOI/STC/SCH] re: seasonal flu  
 
Dear member of staff, 
 
There is currently a confirmed/possible [DELETE AS APPROPRIATE] outbreak of seasonal influenza (‘flu) among 
children in [INSERT INSTITUTION]. Staff members who have influenza like symptoms should remain off work 
until fully recovered (people with flu/other respiratory infections are considered to be infectious to others for 
the duration of their respiratory symptoms).   
 
Staff members in clinical risk groups (see below) should have the flu vaccine every year, available for free via GPs: 
this helps to protect staff members, their families, and children in their care.  
 
Antiviral medication can be offered to those staff members who are at high risk of complications from ‘flu (see 
below) and have either: 
• developed symptoms of ‘flu in the last 48 hours  
• or have had close contact with cases of ‘flu in the last 48 hours (and either not vaccinated or vaccinated 
less than 14 days). 
 
People at high risk of complications from ‘flu (i.e. in clinical risk groups) are those with the following conditions: 
 
• Chronic nerve, liver, kidney, liver, lung and heart disease  
• Diabetes  
• Reduced immune system  
• Age over 65 years  
• Pregnancy (including up to 2 weeks after the birth)  
• Morbid obesity (BMI >=40) 
 
If you have 1 of these conditions and either have symptoms of influenza or are currently working in an area with 
an influenza outbreak: 
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• Please contact the occupational health department or your GP so that you can be assessed for 
antiviral medication. Please note- if you have symptoms, you are infectious to other people (you can 
pass the infection on to others), so please phone ahead before attending the GP practice, this will allow 
the GP practice to put measures in place to minimise the risk of infection to others. 
 
 
Please contact us with any queries. GPs can obtain specialist advice on antiviral medication from PHE virologists 
on [INSERT AS PER LOCAL PROTOCOLS] 
 
Sincerely, 
xxxxxxxxxxxxxxxxxxxxx 
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Appendix 6: The operational dynamic risk 
assessment template  
Public Health Advice from an Outbreak/Incident Control Team (OCT/ICT)  
Guidance notes for completion:  
 
1. This form is to be completed jointly by the PHE lead and the secure setting 
Governor/Director/Manager following an OCT meeting and updated by them at any subsequent OCT.  
 
2. Once completed the form is sent to National Health & Justice PHE by the CCDC/CHP leading the 
response to: Health&Justice@phe.gov.uk (also copy in the PHE Respiratory Diseases Centre: 
Respscidsc@phe.gov.uk) with subject line “Risk assessment [insert specific infectious disease] 
Outbreak HMP [insert prison or institution name]” 
 
3. Additionally, the Governor/Director/Manager should send the completed assessment to HMPPS YCS 
at the email addresses below, with the subject line ‘Outbreak at X [Name of secure setting) 
 
Email to: 
• HMPPS NATIONAL INCIDENT MANAGEMENT UNIT: NIMU@hmps.gsi.gov.uk 
• HMPPS POPULATION MANAGEMENT UNIT: PMS@hmps.gsi.gov.uk 
• HMPPS HEALTH & WELLBEING health.co-comissioning@noms.gsi.gov.uk 
 
Please note that this document, once completed, is subject to the Data Protection Act 
and patient confidentiality protocols - please do not refer to patients by name or provide 
any other patient identifiable information (PPI). 
 
OFFICIAL SENSITIVE ONCE COMPLETE 
 
Required information for risk assessment - please complete as 
much as possible but do not delay sending report while 
awaiting further information eg laboratory results 
Additional Notes: 
Date of Form Completion PHE d/mm/yyyy Governor/Director/Manager: dd/mm/yyyyy 
Date of meeting of OCT/ICT dd/mm/yyyy: Time of first meeting (00:00) 
Name of Secure setting  
Name of PHE Lead and email 
address 
 
Name of 
Governor/Director/Manager 
and email 
 
 Nature of incident: Gastrointestinal disease [] 
Respiratory disease [] 
Specify causative agent if known (eg 
norovirus, influenza A/B, TB etc.) 
Seasonal flu guidance for healthcare and residential staff in the Children and Young People Secure Estate 
 
38 
To be completed by the PHE 
Centre consultant in 
communicable disease 
control/consultant in health 
protection  
Chemical incident [] 
Other [] 
Date of onset of incident or 
date of first case 
dd/mm/yyyy 
People’s affected 
To be completed by the PHE 
Centre consultant in 
communicable disease 
control/consultant in health 
protection  
 
 
Child:  
Suspected [   ] 
Confirmed [   ] 
Staff: 
Suspected [   ] 
Confirmed [    ] 
Are cases confined to 1 
Wing/Area? Y/N 
 
• Has an active case-finding programme 
been recommended? Y/N 
 
o Does case finding include staff? Y/N 
 
• Are any staff on sick leave currently? Y/N 
 
o If Yes, how many [   ] 
 
• Have any (prisoner) cases been 
transferred to hospital for care? Y/N 
 
o If Yes, how many: [   ] 
 
• Any other information: 
 
Public Health Advice from 
OCT  
To be completed by the PHE 
Centre consultant in 
communicable disease 
control/consultant in health 
protection 
 
Has OCT provided recommendation to: 
• Isolate/cohort cases Y/N 
• Provide separate toilet/washing facilities Y/N 
• Restrictions on internal prisoner movements Y/N 
• Stop transfers out Y/N 
• Stop transfer in Y/N 
Movement of Children 
 
Transfer information to be 
completed by the 
Governor/Director/Manager 
Have children at risk of infection been transferred to other secure setting prior 
to quarantine? Y/N (Note 2) 
If Yes, estimate of numbers transferred:[    ] 
List of establishments receiving prisoners: 
1.   
2.      
3.      
4.  
 
Any other information: 
Staff Health & Safety 
To be completed by the PHE 
Centre consultant in 
communicable disease 
control/consultant in health 
protection  
Has OCT recommended 
any specific actions to 
protect staff: 
• PPE Y/N 
• Vaccinations Y/N 
• Testing Y/N 
• Prophylaxis Y/N 
• Treatment Y/N 
Specify nature of advice to protect staff: 
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 • Restrictions on 
activities for vulnerable 
staff Y/N 
Assessment of mortality risk 
To be completed by the PHE 
Centre consultant in 
communicable disease 
control/consultant in health 
protection  
• Has OCT provided 
mortality risk 
assessment Y/N 
 
• Is there a significant 
risk of multiple 
mortalities as result of 
outbreak at this time 
Y/N 
Provide specific information on assessment 
provided by OCT (eg critically ill child(s) in 
hospital): 
 
Additional Information from Governor/ Director/Manager 
Please report any additional relevant information which can assist YCS placements in undertaking a dynamic 
risk assessment: 
 
 
 
 
 
 
 
 
 
 
